[Mechanism of antisense epidermal growth factor receptor cDNA in growth suppression of glioblastomas cells]

Xin-xia Tian1, Ho-keung Ng, Chung-sean Pang

  • 1Department of Pathology, Health Science Center, Peking University, Beijing 100083, China. tianxinxia@yahoo.com

Abstract

Insights

Antisense epidermal growth factor receptor (EGFR) cDNA inhibits glioblastoma cell growth by promoting differentiation, increasing p53 expression, arresting the cell cycle, and reducing telomerase activity.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Glioblastoma is an aggressive brain tumor characterized by overexpression of the epidermal growth factor receptor (EGFR).
  • Targeting EGFR is a key strategy in glioblastoma treatment.
  • Understanding the precise mechanisms of EGFR inhibition is crucial for developing effective therapies.

Purpose of the Study:

  • To elucidate the mechanism by which antisense epidermal growth factor receptor (EGFR) cDNA suppresses glioblastoma cell growth.
  • To investigate the effects of antisense EGFR on cell differentiation, cell cycle progression, and telomerase activity in U87MG cells.

Main Methods:

  • Transfection of U87MG glioblastoma cells with antisense EGFR constructs.
  • Assessment of EGFR protein levels, cell morphology, and glial fibrillary acidic protein (GFAP) expression for differentiation.
  • Flow cytometry and immunohistochemistry to analyze cell cycle distribution and key protein expressions (p53, Rb, p16, CDK4).
  • Telomeric repeat amplification protocol (TRAP) assay to measure telomerase activity.

Main Results:

  • Antisense EGFR transfection led to morphological changes indicative of differentiation (smaller cell bodies, longer processes) and increased GFAP expression.
  • Significant G(0)/G(1) phase arrest and decreased S phase proportion were observed in transfected cells.
  • Wild-type p53 expression was significantly upregulated, while Rb, p16, and CDK4 expressions remained unchanged.
  • Telomerase activity was significantly inhibited in antisense EGFR clones.

Conclusions:

  • Antisense EGFR cDNA effectively inhibits U87MG glioblastoma cell growth.
  • The growth inhibition is mediated through induction of cell differentiation and p53 expression.
  • Cell cycle arrest at the G(1) phase and reduced telomerase activity are key mechanisms involved.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...